Related references
Note: Only part of the references are listed.APP processing in Alzheimer's disease
Yun-Wu Zhang et al.
MOLECULAR BRAIN (2011)
GRK5 Deficiency Accelerates β-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic Activity
Shaowu Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Insulin-like Growth Factor-1 (IGF-1)-induced Processing of Amyloid-β Precursor Protein (APP) and APP-like Protein 2 Is Mediated by Different Metalloproteinases
Kristin T. Jacobsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and Diabetes Mellitus type-2
Massimiliano Plastino et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Linking type 2 diabetes and Alzheimer's disease
Weiping Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimer's Disease: From Model Organisms to Human Disease
S. Freude et al.
CURRENT ALZHEIMER RESEARCH (2009)
RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model
H. J. Cho et al.
FASEB JOURNAL (2009)
Glutamate Acting on N-Methyl-D-aspartate Receptors Attenuates Insulin-like Growth Factor-1 Receptor Tyrosine Phosphorylation and Its Survival Signaling Properties in Rat Hippocampal Neurons
Wen-Hua Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury
Dong-Hyung Cho et al.
SCIENCE (2009)
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases
Lih-Fen Lue et al.
FUTURE NEUROLOGY (2009)
Peripheral elevation of IGF-1 fails to alter Aβ clearance in multiple in vivo models
Thomas A. Lanz et al.
BIOCHEMICAL PHARMACOLOGY (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
β-amyloid1-42 induces neuronal death through the p75 neurotrophin receptor
Areechun Sotthibundhu et al.
JOURNAL OF NEUROSCIENCE (2008)
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Luigi Puglielli
NEUROBIOLOGY OF AGING (2008)
Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers
Fernanda G. De Felice et al.
NEUROBIOLOGY OF AGING (2008)
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
M. S. Beeri et al.
NEUROLOGY (2008)
Functionally significant insulin-like growth factor I receptor mutations in centenarians
Yousin Suh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
R. Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease
Dongfeng Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms
Emmanuel Planel et al.
JOURNAL OF NEUROSCIENCE (2007)
Targeting insulin-like growth factor-1 to treat Alzheimer's disease
Ignacio Torres-Aleman
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
The secreted β-amyloid precursor protein ectodomain APPsα is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice
Sabine Ring et al.
JOURNAL OF NEUROSCIENCE (2007)
IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways
Linda Adlerz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment
Suzanne Craft
CURRENT ALZHEIMER RESEARCH (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: New cues into the human disease?
Eva Carro et al.
NEUROBIOLOGY OF AGING (2006)
Opposing activities protect against age-onset proteotoxicity
Ehud Cohen et al.
SCIENCE (2006)
Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice
J. Svensson et al.
JOURNAL OF ENDOCRINOLOGY (2006)
An aging pathway controls the TrkA to p75NTR receptor switch and amyloid β-peptide generation
Claudio Costantini et al.
EMBO JOURNAL (2006)
Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease:: review and hypothesis
WQ Qiu et al.
NEUROBIOLOGY OF AGING (2006)
Peripheral hyperinsulinemia promotes tau phosphorylation in vivo
S Freude et al.
DIABETES (2005)
Tau is hyperphosphorylated in the insulin-like growth factor-I null brain
CM Cheng et al.
ENDOCRINOLOGY (2005)
Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia
E Emanuele et al.
ARCHIVES OF NEUROLOGY (2005)
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
GK Gouras et al.
NEUROBIOLOGY OF AGING (2005)
Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice
LY Sun et al.
NEUROBIOLOGY OF AGING (2005)
A biochemical and functional characterization of diet-induced brain insulin resistance
JG Mielke et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Differential effects of oligomeric and fibrillar amyloid-β1-42 on astrocyte-mediated inflammation
JA White et al.
NEUROBIOLOGY OF DISEASE (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Midlife cardiovascular risk factors and risk of dementia in late life
RA Whitmer et al.
NEUROLOGY (2005)
Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain
QX Ding et al.
NEUROSCIENCE LETTERS (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Akt activity in Alzheimer's disease and other neurodegenerative disorders
A Rickle et al.
NEUROREPORT (2004)
The source of cerebral insulin
WA Banks
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Signaling by insulin-like growth factor 1 in brain
CA Bondy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease
E Carro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD
G Ahmadian et al.
EMBO JOURNAL (2004)
Role for neuronal insulin resistance in neurodegenerative diseases
M Schubert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Insulin stimulates interleukin-6 and tumor necrosis factor-α gene expression in human subcutaneous adipose tissue
R Krogh-Madsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention
LX Zhao et al.
JOURNAL OF NEUROSCIENCE (2004)
Hyperinsulinemia and risk of Alzheimer disease
JA Luchsinger et al.
NEUROLOGY (2004)
Role of insulin-like growth factor I in maintaining normal glucose homeostasis
DR Clemmons
HORMONE RESEARCH (2004)
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI
T den Heijer et al.
DIABETOLOGIA (2003)
Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice
JG Sheng et al.
NEUROBIOLOGY OF DISEASE (2003)
Diabetes, Alzheimer's disease and apolipoprotein genotype
C Messier
EXPERIMENTAL GERONTOLOGY (2003)
Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype
S Craft et al.
PSYCHONEUROENDOCRINOLOGY (2003)
Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling
AM Johnston et al.
FEBS LETTERS (2003)
Insulin-like growth factor I (IGF-I) and cognitive decline in older persons
MG Dik et al.
NEUROBIOLOGY OF AGING (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis (Withdrawn Publication. See vol. 298, 2022) (Withdrawn Publication. See vol. 298, 2022)
L Puglielli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
γ-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
WT Kimberly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Soluble tumor necrosis Factor-α receptors in young obese subjects with normal and impaired glucose tolerance
S Dzienis-Straczkowska et al.
DIABETES CARE (2003)
The induction of the TNFα death domain signaling pathway in Alzheimer's disease brain
M Zhao et al.
NEUROCHEMICAL RESEARCH (2003)
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
EM Mandelkow et al.
NEUROBIOLOGY OF AGING (2003)
Insulin and the blood-brain barrier
SC Woods et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
The role of insulin in human brain glucose metabolism -: An 18fluoro-deoxyglucose positron emission tomography study
EM Bingham et al.
DIABETES (2002)
Alzheimer's disease: treatments in discovery and development
M Citron
NATURE NEUROSCIENCE (2002)
The role of mitogen-activated protein kinase pathways in Alzheimer's disease
XW Zhu et al.
NEUROSIGNALS (2002)
Region-specific alterations in insulin-like growth factor receptor type I in the cerebral cortex and hippocampus of aged rats
YH Chung et al.
BRAIN RESEARCH (2002)
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease
A Delacourte et al.
NEUROLOGY (2002)
The spin trapping agent PBN stimulates H2O2-induced Erk and Src kinase activity in human neuroblastoma cells
P Kelicen et al.
NEUROREPORT (2002)
Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans
M Soop et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
Ablation of insulin-producing neurons in flies: Growth and diabetic phenotypes
EJ Rulifson et al.
SCIENCE (2002)
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies - The Honolulu-Asia Aging Study
R Peila et al.
DIABETES (2002)
Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca2+ and PI3-kinase
AJ Crossthwaite et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Genetics of interleukin 6: implications for Alzheimer's disease
A Papassotiropoulos et al.
NEUROBIOLOGY OF AGING (2001)
Interleukin-1, neuroinflammation, and Alzheimer's disease
RE Mrak et al.
NEUROBIOLOGY OF AGING (2001)
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism
LF Lue et al.
EXPERIMENTAL NEUROLOGY (2001)
Oxidative damage is the earliest event in Alzheimer disease
A Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis
VA Skeberdis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats
LP Reagan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Insulin receptors and insulin action in the brain: review and clinical implications
RJ Schulingkamp et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update
S Hoyer
EXPERIMENTAL GERONTOLOGY (2000)
Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity
JP Bastard et al.
DIABETES OBESITY & METABOLISM (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-Golgi network
DM Skovronsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Constitutive overactivation of protein kinase C in guinea pig brain increases alpha-secretory APP processing without decreasing beta-amyloid generation
S Rossner et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons
M Lesort et al.
NEUROSCIENCE (2000)
Share Paper
